Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-SARS-CoV-2 Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05047952
What this trial is testing

Vortioxetine for Post-COVID-19 Condition

Who this might be right for
Post-COVID-19 ConditionPost-COVID-19 SyndromeCognitive Impairment
Brain and Cognition Discovery Foundation 149
Not applicableUnknownNCT04292340
What this trial is testing

Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of COVID-19

Who this might be right for
Coronavirus
Shanghai Public Health Clinical Center 15
Not applicableStudy completedNCT05926518
What this trial is testing

Anti-Xa Level With Thromboprophylactic Dosage Nadroparin in Critically Ill COVID-19 and Non-COVID-19 Patients

Who this might be right for
Critical IllnessTherapeutic Drug MonitoringVenous Thromboembolism
Rijnstate Hospital 62
Testing effectiveness (Phase 2)Study completedNCT04364737
What this trial is testing

CONTAIN COVID-19: Convalescent Plasma to Limit COVID-19 Complications in Hospitalized Patients

Who this might be right for
COVID-19CoronavirusCoronavirus Infection
NYU Langone Health 941
Not applicableUnknownNCT05664919
What this trial is testing

Efficacy and Safety of Anti-COVID-19 Antibody SA58 Nasal Spray to Prevent Infection in High-risk Populations

Who this might be right for
COVID-19
Sinovac Life Sciences Co., Ltd. 7,000
Testing effectiveness (Phase 2)Study completedNCT04374565
What this trial is testing

Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia

Who this might be right for
Corona Virus InfectionSARS-CoV 2SARS Pneumonia+1 more
University of Virginia 29
Not applicableStudy completedNCT05439044
What this trial is testing

A Real-World Study of Anti-SARS-CoV-2 Monoclonal Antibodies in Prophylaxis and Curative of Covid-19 (COVIMAB)

Who this might be right for
Immunocompromised Patients
Assistance Publique - Hôpitaux de Paris 4,235
Testing effectiveness (Phase 2)Study completedNCT04524507
What this trial is testing

Coronavirus Disease 2019 (COVID-19) Antibody Plasma Research Study in Hospitalized Patients

Who this might be right for
COVID-19
University of North Carolina, Chapel Hill 56
Very early researchEnded earlyNCT04353206
What this trial is testing

Convalescent Plasma in ICU Patients With COVID-19-induced Respiratory Failure

Who this might be right for
Covid-19Sars-CoV2
Noah Merin 6
Not applicableUnknownNCT05162456
What this trial is testing

Determinants of the Level of Anti-SARS-CoV-2 IgG ANTibodiEs After Vaccination Study in Patients After Organ Transplantation

Who this might be right for
SARS-CoV2 InfectionSARS-CoV2 Antibodies
Collegium Medicum w Bydgoszczy 250
Large-scale testing (Phase 3)Ended earlyNCT05074433
What this trial is testing

Evaluate Efficacy and Safety of Casirivimab+Imdevimab (Monoclonal Antibodies) for Prevention of COVID-19 in Immunocompromised Adolescents and Adults

Who this might be right for
Immunocompromised
Regeneron Pharmaceuticals 66
Not applicableStudy completedNCT06259656
What this trial is testing

Correlation of Antibody Response to COVID-19 Vaccination in Pregnant Woman and Transplacental Passage Into Cord Blood.

Who this might be right for
Covid-19
Vachira Phuket Hospital 40
Not applicableUnknownNCT04367402
What this trial is testing

COST (COvid STudio) ACTION: Study for the Evaluation of Specific Antibodies Anti Covid-19 Linked to Covid-19 Infection, Symptoms and Genetic Expression of ACE2 Polymorphisms in Patients (COST ACTION)

Who this might be right for
COVID-19
Azienda Ospedaliera San Paolo 600
Testing effectiveness (Phase 2)Study completedNCT04354831
What this trial is testing

Efficacy and Safety of Convalescent Plasma in Treating COVID-19 Hospitalized Patients

Who this might be right for
COVID-19
Medical College of Wisconsin 131
Post-approval studies (Phase 4)Looking for participantsNCT06452654
What this trial is testing

Anti-viral Action Against Type 1 Diabetes Autoimmunity

Who this might be right for
Diabetes Mellitus, Type 1
Technical University of Munich 2,252
Testing effectiveness (Phase 2)Study completedNCT04398004
What this trial is testing

Anti-inflammatory Clarithromycin for Improving COVID-19 Infection Early

Who this might be right for
COVID-19Virus DiseasesCorona Virus Infection
Hellenic Institute for the Study of Sepsis 90
Testing effectiveness (Phase 2)Study completedNCT04920916
What this trial is testing

Safety and Efficacy of Dupilumab for Treatment of Hospitalized COVID-19 Patients

Who this might be right for
COVID-19
University of Virginia 40
Very early researchWithdrawnNCT04570449
What this trial is testing

Fluoxetine to Reduce Hospitalization From COVID-19 Infection (FloR COVID-19)

Who this might be right for
Covid19
Milton S. Hershey Medical Center
Testing effectiveness (Phase 2)UnknownNCT04413838
What this trial is testing

Efficiency and Security of NIVOLUMAB Therapy in Obese Individuals With COVID-19(COrona VIrus Disease) Infection

Who this might be right for
Obesity, COVID-19 Infection
Hospices Civils de Lyon 120
Not applicableStudy completedNCT04442087
What this trial is testing

Study of Seroprevalence of Anti-SARS-CoV2 Among Children of Hospital Workers in AP-HP

Who this might be right for
SARS-CoV2
Assistance Publique - Hôpitaux de Paris 563
Next Page